Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,185,245
+$538,584 QoQ
Shares Held
32,374
-27.3% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 211 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. ANAB ranks #150 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in ANAB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,185,245 | 32,374 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,646,661 | 29,691 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,260,722 | 26,005 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $9,164,887 | 299,311 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $14,944,396 | 673,171 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,011,309 | 915,081 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $12,247,138 | 925,007 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,924,372 | 923,117 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $7,523,627 | 300,224 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,866,427 | 171,689 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,964,170 | 231,754 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $4,064,012 | 226,282 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $389,823 | 12,579 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $312,727 | 12,259 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $222,954 | 10,983 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $268,972 | 10,872 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $361,296 | 10,397 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $220,756 | 8,140 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $214,337 | 8,266 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $210,759 | 9,780 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,157,419 | 332,904 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||